Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Community Research Initiative of New England |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002092 |
To determine the change in CD4 count after 4 and 8 weeks in HIV-infected patients treated with cimetidine compared to placebo. To observe time-associated trends at weeks 4, 8, 12, and 16 in the change of CD4 counts for patients taking cimetidine for the full 16 weeks. To establish a safety record for cimetidine use in HIV-positive patients.
Condition | Intervention |
---|---|
HIV Infections |
Drug: Cimetidine |
Study Type: | Interventional |
Study Design: | Treatment, Placebo Control, Safety Study |
Official Title: | A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Concurrent Medication:
Allowed:
Patients must have:
HIV positivity.
NOTE:
NOTE:
Prior Medication:
Allowed:
Exclusion Criteria:
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Concurrent Medication:
Excluded:
Prior Medication:
Excluded within 4 weeks prior to study entry:
Study ID Numbers: | 119A, 92-01 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002092 |
Health Authority: | United States: Food and Drug Administration |
Acquired Immunodeficiency Syndrome AIDS-Related Complex Cimetidine |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Histamine phosphate |
AIDS-Related Complex Cimetidine Retroviridae Infections Immunologic Deficiency Syndromes Histamine |
Communicable Diseases RNA Virus Infections Neurotransmitter Agents Slow Virus Diseases Immune System Diseases Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Gastrointestinal Agents Histamine Agents |
Enzyme Inhibitors Infection Pharmacologic Actions Histamine H2 Antagonists Histamine Antagonists Therapeutic Uses Anti-Ulcer Agents Lentivirus Infections |